Fibrinolytic and Non-fibrinolytic Roles of Tissue-type Plasminogen Activator in the Ischemic Brain

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved..

The neurovascular unit (NVU) is assembled by endothelial cells (ECs) and pericytes, and encased by a basement membrane (BM) surveilled by microglia and surrounded by perivascular astrocytes (PVA), which in turn are in contact with synapses. Cerebral ischemia induces the rapid release of the serine proteinase tissue-type plasminogen activator (tPA) from endothelial cells, perivascular astrocytes, microglia and neurons. Owning to its ability to catalyze the conversion of plasminogen into plasmin, in the intravascular space tPA functions as a fibrinolytic enzyme. In contrast, the release of astrocytic, microglial and neuronal tPA have a plethora of effects that not always require the generation of plasmin. In the ischemic brain tPA increases the permeability of the NVU, induces microglial activation, participates in the recycling of glutamate, and has various effects on neuronal survival. These effects are mediated by different receptors, notably subunits of the N-methyl-D-aspartate receptor (NMDAR) and the low-density lipoprotein receptor-related protein-1 (LRP-1). Here we review data on the role of tPA in the NVU under non-ischemic and ischemic conditions, and analyze how this knowledge may lead to the development of potential strategies for the treatment of acute ischemic stroke patients.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:542

Enthalten in:

Neuroscience - 542(2024) vom: 26. März, Seite 69-80

Sprache:

Englisch

Beteiligte Personen:

Yepes, Manuel [VerfasserIn]

Links:

Volltext

Themen:

EC 3.4.21.68
EC 3.4.21.7
Excitotoxicity
Fibrinolysin
Fibrinolytic Agents
Journal Article
Low-density lipoprotein receptor-related protein-1 (LRP-1)
N-methyl-D-aspartate receptor (NMDAR)
Neurovascular unit (NVU)
Plasmin
Review
Tissue Plasminogen Activator
Tissue-type plasminogen activator (tPA)

Anmerkungen:

Date Completed 18.03.2024

Date Revised 18.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.neuroscience.2023.08.011

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM360735959